![]() | Dr. Ferris on Ongoing Research With STING Agonists/Checkpoint Inhibitors in Head and Neck Cancer Süre: 1:09 | Boyut: 2.63 MB |
![]() | Dr. Ferris on a Trial Testing ADU-S100/MIW815/Pembrolizumab in Head and Neck Cancer Süre: 0:54 | Boyut: 2.06 MB |
![]() | Dr. Ferris on FDA Approval of Nivolumab in Patients With Head and Neck Cancer Süre: 1:17 | Boyut: 2.94 MB |
![]() | Dr. Ferris on the Safety Profile of Transoral Robotic Surgical Resection in Oropharynx Cancer Süre: 1:16 | Boyut: 2.9 MB |
![]() | Dr. Ferris on Combining STING Agonists With Checkpoint Inhibitors in Head and Neck Cancer Süre: 0:53 | Boyut: 2.02 MB |
![]() | Dr. Ferris on Impact of FDA Approval of Pembrolizumab in Patients With Head and Neck Cancer Süre: 1:44 | Boyut: 3.97 MB |
![]() | Dr. Ferris on Combining Immunotherapy and Radiation Therapy in Head and Neck Cancer Süre: 1:20 | Boyut: 3.05 MB |
![]() | Dr. Ferris on the Updated Data from CheckMate-141 in Head and Neck Cancer Süre: 2:01 | Boyut: 4.62 MB |
![]() | Dr. Ferris on Significance of CheckMate-141 Trial for Head and Neck Cancer Süre: 1:15 | Boyut: 2.86 MB |